PATENT CLAIM ANALYSIS

Application Number: 15923275
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["514", "005500"]

Abstract:
This invention relates to treating gastrointestinal dysfunction with erythropoietin (EPO) or its analog.

Claim (Index 4):
The method of  claim 2 , wherein the congenital problem is selected from the group consisting of Gastroschisis, omphalocele, aganglionic megacolon, Hirschprung's disease, chronic intestinal pseudo-obstruction, small left colon syndrome, anorectal anomalies, esophageal dysplasia and atresias, ectopic anus, congenital hernias, and internal anal sphincter achalasia.

Metadata:
- Claim Count in Document: 47.0
- Percentile: 90.0
- Lexical Diversity: 1.0
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15136160', '13073275', '09717053', '15703457', '09716960']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7986122527616888
- 35 USC 102 Novelty (BERT): 0.511734891602545
- Combined Prediction Score: 0.7699245166457744
- Mean Citation Score: 210.323432
- Max Citation Score: 221.60922
- Similarity Product: 124.14274546781658

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test